Dr. Donehower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1980
- Johns Hopkins UniversityResidency, Internal Medicine, 1974 - 1976
- University of Minnesota Medical SchoolClass of 1974
Certifications & Licensure
- MD State Medical License 1979 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Excellence in Teaching Award American Society of Clinical Oncology, 2017
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Penclomedine in Treating Patients With Advanced Solid Tumors Start of enrollment: 1996 Dec 01
- UCN-01 in Treating Patients With Advanced Cancer Start of enrollment: 1998 Jun 01
- MG98 in Treating Patients With Advanced Solid Tumors Start of enrollment: 1999 Feb 22
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsRAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma.Fanfan Xie, Ding Ding, Cong Lin, Dea Cunningham, Michael Wright, Ammar A Javed, Nilo Azad, Valerie Lee, Ross Donehower, Ana De Jesus-Acosta, Dung T Le, Michael Pishvai...> ;JCO Precision Oncology. 2022 Jun 1
- 2 citationsTrainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.Laura A. Sena, Ramy Sedhom, Susan C. Scott, Amanda Kagan, Andrew H. Marple, Jenna Van Liere Canzoniero, Melinda Hsu, Syed Mohammed Qasim Hussaini, Amin S. Herati, Laur...> ;JCO Oncology Practice. 2021 Sep 25
- 8 citationsChallenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.Ding Ding, Ammar A. Javed, Dea Cunningham, Jonathan Teinor, Michael J. Wright, Zunaira N. Javed, Cara Wilt, Lindsay Parish, Mary Hodgin, Amy Ryan, Carol Judkins, Keith...> ;Cancer Letters. 2021 Jan 28
- Join now to see all
Press Mentions
- Johns Hopkins University Hematology Oncology FellowshipApril 30th, 2017
Grant Support
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1997–2007
- Phase I Trial/Pharmacokinetis Of Tas 103 Solid In TumorsNational Center For Research Resources2000–2002
- Trial Of Bryostatin 1 Given As Continuous Infusion In Cancer PatientsNational Center For Research Resources1998–2002
- Phase I Dose Escalation, Safety, Tolerability Of Tas 103National Center For Research Resources1997–2002
- Phase I Trials Of Anticancer AgentsNational Cancer Institute1998–2000
- Phase II Pharm Study--Flavopiradol (Nsc 649890) In Colorectal CancerNational Center For Research Resources1999
- Phase II Trials Of New Anticancer AgentsNational Cancer Institute1994–1998
- Phase I Clinical Trial Of Anticancer AgentsNational Cancer Institute1995–1997
- Pharmacokinetic Studies Of Anticancer AgentstheDivision Of Cancer Treatment1994–1995
- Navelbine Bioavailability In Solid Tumors And LymphomaNational Center For Research Resources1992–1993
- 7u85 Mesylate Intravenous Administration Daily For Five DaysNational Center For Research Resources1992–1993
- Phase I And Pharmacokinetic Studies Of Anticancer AgentsDivision Of Cancer Treatment1990–1993
- Bioavailability Of Piritrexim Isethionate In Advanced Cancer PatientsNational Center For Research Resources1992
Professional Memberships
- Fellow
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ross-donehower
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: